Journals / Journal of Contemporary Medicine / 2022 / Cilt: 12 - Sayı: 2

Relationship between myalgia and laboratory parameters in hospitalized patients with COVID-19

Hospitalize Hastalarda Miyalji ve Laboratuar Parametreleri Arasındaki ilişki

Pages
306–311
Publication Date
2022-03-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, creatine kinase (CK) levels were found to be significantly higher in the group with myalgia compared with the group without myalgia (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Myalgia is among the first and most common symptoms in patients with COVID-19.
📊
Key Findings & Data:In this study, we aimed to evaluate the prevalence of myalgia and the relationship between myalgia and laboratory parameters in patients who were hospitalized due to COVID-19.
💡
Conclusion & Impact:However, creatine kinase (CK) levels were found to be significantly higher in the group with myalgia compared with the group without myalgia (p
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:COVID-19 · kreatin kinaz · miyalji

Abstract

Aim: Myalgia is among the first and most common symptoms in patients with COVID-19. A limited number of studies have been found evaluating the frequency of myalgia and the laboratory findings associated with this condition. In this study, we aimed to evaluate the prevalence of myalgia and the relationship between myalgia and laboratory parameters in patients who were hospitalized due to COVID-19. Material and Methods: Three hundred fifty-eight patients with confirmed diagnoses of COVID-19 who were hospitalized between March 2020 and January 2021 were included in the study. The patients were divided into two groups according to the presence and absence of myalgia. Demographic characteristics, medical history, symptoms, clinical findings, and laboratory findings were evaluated retrospectively. Results: A total of 358 patients, 192 (42.9%) females and 166 males, were included in the study. The mean age of the patients was 60.3 ± 15.2 years. When the laboratory findings of the 166 patients with myalgia and 192 patients with no myalgia were compared, no difference was found between the groups in terms of white blood cell, neutrophil, lymphocyte, monocyte, and platelet counts, C-reactive protein, ferritin D-dimer, and troponin levels. However, creatine kinase (CK) levels were found to be significantly higher in the group with myalgia compared with the group without myalgia (p

Özet

Amaç: COVID-19 hastalarında miyalji ilk ve en yaygın semptomlar arasında yer almaktadır. Miyalji sıklığını ve bu durumla ilişkili laboratuar bulgularını değerlendiren sınırlı sayıda çalışmaya rastlanılmıştır. Bu çalışmada hastalığı daha şiddetli olması sebebiyle hospitalize takip edilen hastalarda miyalji sıklığını ve miyalji ile laboratuar parametreleri arasındaki ilişkiyi değerlendirmeyi amaçladık. Yöntem: Bu çalışmaya Mart 2020- Ocak 2021 tarihleri arasında hastanede yatırılarak takip edilen COVID-19 tanısı doğrulanmış 358 hasta dahil edilmiştir. Miyalji varlığı ve yokluğuna göre hastalar 2 gruba ayrılmıştır. Demografik özellikler, tıbbi geçmiş, semptomlar, klinik bulgular ve laboratuvar bulguları retrospektif olarak değerlendirildi. Bulgular: Bu çalışmaya 192'si (% 42,9) kadın, 166’sı erkek olmak üzere toplam 358 hasta dahil edildi. Hastaların yaş ortalaması 60,3 ± 15,2 idi. Miyalji tarifleyen 166 hasta ve tariflemeyen 192 hastanın laboratuar bulguları karşılaştırıldığında, white blood cell (WBC), neutrophil, lymphocyte, monocyte, platelet değerleri, C reactive protein (CRP), ferritin D-dimer, troponin düzeyleri arasında gruplar arası fark saptanmadı. Ancak miyalji olan grupta olmayan gruba göre creatine kinase (CK) düzeyleri anlamlı yüksek saptandı (p

🔖

Cite This Article

OKUYAN, D. Y., GÖLEN, M. K. (2022). Relationship between myalgia and laboratory parameters in hospitalized patients with COVID-19. Journal of Contemporary Medicine, Cilt: 12 - Sayı: 2, 306–311. https://ajindex.com/articles/774861

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. World Health Organization. Coronavirus disease 2019 (COVID-19) Dashboard 2020; 2020
  2. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020 Jun 1;77(6):683-690. doi: 10.1001/jamaneurol.2020.1127 3. Baig AM. Neurological manifestations in COVID-19 caused by SARS-CoV-2. CNS Neurosci Ther. 2020 May;26(5):499-501. doi: 10.1111/cns.13372
  3. Li LQ, Huang T, Wang YQ, Wang ZP, Liang Y, Huang TB, et al. COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020 Jun;92(6):577-583. doi: 10.1002/jmv.25757
  4. Huang YH, Wu CY, Hsieh YW, Lin KC. Predictors of change in quality of life after distributed constraint-induced therapy in patients with chronic stroke. Neurorehabil Neural Repair. 2010 Jul-Aug;24(6):559-66. doi: 10.1177/1545968309358074
  5. Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244
  6. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3
  7. Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261. doi: 10.1007/s00405-020-05965-1
  8. World Health Organization. Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance. 2020
  9. Hoong CWS, Amin MNME, Tan TC, Lee JE. Viral arthralgia a new manifestation of COVID-19 infection? A cohort study of COVID-19-associated musculoskeletal symptoms. Int J Infect Dis. 2021 Mar;104:363-369. doi: 10.1016/j.ijid.2021.01.031
  10. Escalera-Antezana JP, Lizon-Ferrufino NF, Maldonado-Alanoca A, Alarcón-De-la-Vega G, Alvarado-Arnez LE, Balderrama-Saavedra MA, et al; LANCOVID. Clinical features of the first cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain. Travel Med Infect Dis. 2020 May-Jun;35:101653. doi: 10.1016/j.tmaid.2020.101653
  11. Lechien JR, Chie